NVOH vs. VEA
Compare and contrast key facts about Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Vanguard FTSE Developed Markets ETF (VEA).
NVOH and VEA are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. NVOH is an actively managed fund by Precidian. It was launched on Jan 2, 2025. VEA is a passively managed fund by Vanguard that tracks the performance of the FTSE Developed All Cap ex US Index. It was launched on Jul 20, 2007.
Performance
NVOH vs. VEA - Performance Comparison
Loading graphics...
NVOH vs. VEA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | -24.75% | -42.98% |
VEA Vanguard FTSE Developed Markets ETF | 4.45% | 33.79% |
Returns By Period
In the year-to-date period, NVOH achieves a -24.75% return, which is significantly lower than VEA's 4.45% return.
NVOH
- 1D
- -1.00%
- 1M
- 0.42%
- YTD
- -24.75%
- 6M
- -34.28%
- 1Y
- -46.24%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
VEA
- 1D
- 1.65%
- 1M
- -5.45%
- YTD
- 4.45%
- 6M
- 9.91%
- 1Y
- 31.74%
- 3Y*
- 16.71%
- 5Y*
- 8.93%
- 10Y*
- 9.55%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NVOH vs. VEA - Expense Ratio Comparison
NVOH has a 0.19% expense ratio, which is higher than VEA's 0.03% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Return for Risk
NVOH vs. VEA — Risk / Return Rank
NVOH
VEA
NVOH vs. VEA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Vanguard FTSE Developed Markets ETF (VEA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVOH | VEA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.88 | 1.81 | -2.69 |
Sortino ratioReturn per unit of downside risk | -1.14 | 2.46 | -3.60 |
Omega ratioGain probability vs. loss probability | 0.84 | 1.36 | -0.52 |
Calmar ratioReturn relative to maximum drawdown | -0.89 | 2.77 | -3.66 |
Martin ratioReturn relative to average drawdown | -1.51 | 10.77 | -12.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NVOH | VEA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.88 | 1.81 | -2.69 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.55 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.55 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.98 | 0.22 | -1.20 |
Correlation
The correlation between NVOH and VEA is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NVOH vs. VEA - Dividend Comparison
NVOH's dividend yield for the trailing twelve months is around 4.56%, more than VEA's 2.88% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 4.56% | 2.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VEA Vanguard FTSE Developed Markets ETF | 2.88% | 3.22% | 3.35% | 3.15% | 2.91% | 3.16% | 2.04% | 3.04% | 3.35% | 2.77% | 3.05% | 2.92% |
Drawdowns
NVOH vs. VEA - Drawdown Comparison
The maximum NVOH drawdown since its inception was -61.60%, roughly equal to the maximum VEA drawdown of -60.68%. Use the drawdown chart below to compare losses from any high point for NVOH and VEA.
Loading graphics...
Drawdown Indicators
| NVOH | VEA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.60% | -60.68% | -0.92% |
Max Drawdown (1Y)Largest decline over 1 year | -53.00% | -11.63% | -41.37% |
Max Drawdown (5Y)Largest decline over 5 years | — | -29.71% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.73% | — |
Current DrawdownCurrent decline from peak | -60.40% | -7.20% | -53.20% |
Average DrawdownAverage peak-to-trough decline | -36.02% | -13.39% | -22.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.21% | 2.99% | +28.22% |
Volatility
NVOH vs. VEA - Volatility Comparison
Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Vanguard FTSE Developed Markets ETF (VEA) have volatilities of 8.19% and 7.92%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NVOH | VEA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.19% | 7.92% | +0.27% |
Volatility (6M)Calculated over the trailing 6-month period | 37.53% | 11.68% | +25.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.51% | 17.67% | +34.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.04% | 16.30% | +34.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.04% | 17.26% | +33.78% |